Patents by Inventor Bryan THACKER

Bryan THACKER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • In vitro heparin and heparan sulfate compositions and methods of making and using
    Patent number: 12636307
    Abstract: Disclosed herein are cellular derived heparin and heparan sulfate compositions, methods of making and using, and cell lines for making and using.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: May 26, 2026
    Assignee: TEGA THERAPEUTICS, INC.
    Inventors: Charles Glass, Bryan Thacker, Jeffrey Esko
  • CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING
    Publication number: 20240026404
    Abstract: Disclosed herein are substantially pure glycosaminoglycan compositions derived from genetically modified cells.
    Type: Application
    Filed: December 9, 2022
    Publication date: January 25, 2024
    Inventors: Charles GLASS, Bryan THACKER, Jeffrey ESKO
  • Cellular glycosaminoglycan compositions and methods of making and using
    Patent number: 11549000
    Abstract: Disclosed herein are substantially pure glycosaminoglycan compositions derived from genetically modified cells.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: January 10, 2023
    Assignee: TEGA Therapeutics, Inc.
    Inventors: Charles Glass, Bryan Thacker, Jeffrey Esko
  • HEPARIN AND HEPARAN SULFATE FROM MODIFIED MST CELLS AND METHODS OF MAKING AND USING
    Publication number: 20220305049
    Abstract: Abstract: Provided herein are methods of producing heparin and heparan sulfate from modified cells, such as modified MST cells and modified basophil neoplastic cells, and compositions comprising heparin and heparan sulfate isolated from modified cells. In some embodiments, methods herein comprise culturing a genetically modified cell line comprising at least one of a mastocytoma cell line and a basophil neoplastic cell line; and isolating the heparin or heparan sulfate from the cell line.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 29, 2022
    Inventors: Charles GLASS, Bryan THACKER, Jeffrey D. ESKO
  • CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING
    Publication number: 20200332088
    Abstract: Disclosed herein are substantially pure glycosaminoglycan compositions derived from genetically modified cells.
    Type: Application
    Filed: December 16, 2016
    Publication date: October 22, 2020
    Applicant: TEGA Therapeutics, Inc.
    Inventors: Charles GLASS, Bryan THACKER, Jeffrey ESKO
  • IN VITRO HEPARIN AND HEPARAN SULFATE COMPOSITIONS AND METHODS OF MAKING AND USING
    Publication number: 20200038430
    Abstract: Disclosed herein are cellular derived heparin and heparan sulfate compositions, methods of making and using, and cell lines for making and using.
    Type: Application
    Filed: December 15, 2017
    Publication date: February 6, 2020
    Inventors: Charles GLASS, Bryan THACKER, Jeffrey ESKO